DLL4
- 1 lab in 1 country
- Funders: Boston Scientific Corporation and 2 more
- Humans1
- Animals1
Effects
1Atherosclerotic plaque stability
downin mice1
1 study
Atherosclerotic plaque stability
downin mice1
DLL4 decreases atherosclerotic plaque stability in mice.
“macrophage-specific knockout of Delta-like ligand 4 in atherosclerotic mice leads to reduced plaque burden and improved stability”
Animalsshown by macrophage-specific knockout
Nature communications12 Feb 2024
Latest
Nature Communications
Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling
Cohort study in peopleMechanisms
Journal of Genetics and Genomics
Embryonic lineage tracing with Procr-CreER marks balanced hematopoietic stem cell fate during entire mouse lifespan
Experiments in miceBlood and immune system